Hypertriglyceridemia clinical trials at University of California Health
2 research studies open to eligible people
Showing trials for
Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
open to eligible people ages 18 years and up
The purpose of the study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.
at UCSD
Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia
open to eligible people ages 18 years and up
The purpose of the study is to evaluate the effect of olezarsen on percent change in fasting triglyceride (TG) levels compared to placebo in participants with hypertriglyceridemia and atherosclerotic cardiovascular disease, or with severe hypertriglyceridemia.
at UCLA UCSD
Last updated: